Recent advances in understanding molecular mechanisms in the pathogenesis and antibody profile of Sjögren’s syndrome
- 1 August 2003
- journal article
- review article
- Published by Springer Nature in Current Rheumatology Reports
- Vol. 5 (4) , 311-316
- https://doi.org/10.1007/s11926-003-0010-z
Abstract
Sjögren’s syndrome is a chronic autoimmune and rheu-matic disorder of the mucous membranes caused by a lack of proper exocrine secretions, with prominent sicca complaints. The molecular mechanisms of the pathogene-sis are virtually unknown, although progress has been made with regard to chemokines, B cell activating factor, and apoptosis. A large number of autoantibodies have been reported in Sjögren’s syndrome, some of which relate to impairment of glandular function. Sjögren’s syn-drome is a female-dominant disease with a late age of onset; most patients contract the disease at the age of 40 to 50 years. Lately, attention has been drawn to the effects of adrenopause in Sjögren’s syndrome and on dehydroepiandrosterone and its intracrine metabolism in target tissues. This can influence the maintenance and remodeling of exocrine glands and may explain, in part, another important disease symptom—fatigue.Keywords
This publication has 47 references indexed in Scilit:
- The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndromeAnnals of the Rheumatic Diseases, 2003
- Increased salivary gland tissue expression of Fas, Fas ligand, cytotoxic T lymphocyte–associated antigen 4, and programmed cell death 1 in primary Sjögren's syndromeArthritis & Rheumatism, 2003
- Involvement of the interferon‐γ–induced T cell–attracting chemokines, interferon‐γ–inducible 10‐kd protein (CXCL10) and monokine induced by interferon‐γ (CXCL9), in the salivary gland lesions of patients with Sjögren's syndromeArthritis & Rheumatism, 2002
- Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjögren's syndromeArthritis & Rheumatism, 2002
- Treatment with infliximab restores normal aquaporin 5 distribution in minor salivary glands of patients with Sjögren's syndromeArthritis & Rheumatism, 2002
- Role of Salivary IgA in the Pathogenesis of Sjögren SyndromeClinical Immunology, 2002
- Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus GroupAnnals of the Rheumatic Diseases, 2002
- Abnormal B Cell Differentiation in Primary Sjögren's Syndrome Results in a Depressed Percentage of Circulating Memory B Cells and Elevated Levels of Soluble CD27 That Correlate with Serum IgG ConcentrationClinical Immunology, 2002
- Sjögren's syndrome: viewpoint on pathogenesisScandinavian Journal of Rheumatology, 2002
- Autoantibodies in Primary Sjögren's Syndrome: New Insights into Mechanisms of Autoantibody Diversification and Disease PathogenesisAutoimmunity, 2001